Canadian vaccine-maker Medicago says COVID shot 71 per cent effective, including most variants

The maker of the leading Canadian-developed COVID vaccine has released promising data from its third phase of clinical testing - suggesting a high level of efficacy against most variants of the coronavirus - and says a final application will be handed to Health Canada within days.